Linked Life Data

16720422

Source:http://linkedlifedata.com/resource/pubmed/id/16720422

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-5-24
pubmed:abstractText
It is estimated that 30% to 50% of heart failure patients have preserved systolic left ventricular (LV) function, often referred to as diastolic heart failure (DHF). Mortality is high in this patient population, and morbidity and rate of hospitalization are similar to those of patients with systolic heart failure. The management of patients with diastolic heart failure is essentially empirical, limited, and disappointing. New drugs, devices, and gene therapy based treatment options are currently under investigation. In this review, future strategies for the treatment of diastolic heart failure are discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1748-2941
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13-20
pubmed:dateRevised
2009-11-17
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Future strategies for the treatment of diastolic heart failure.
pubmed:affiliation
GeneGrafts Limited, Haifa, Israel. feld@genegrafts.com
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't